|
A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen for the treatment of bee and wasp venom allergy |
Hockenhull J, Elremeli M, Cherry MG, Mahon J, Lai M, Darroch J, Oyee J, Boland A, Dickson R, Dundar Y, Boyle R |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Hockenhull J, Elremeli M, Cherry MG, Mahon J, Lai M, Darroch J, Oyee J, Boland A, Dickson R, Dundar Y, Boyle R. A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen for the treatment of bee and wasp venom allergy. Health Technology Assessment 2012; 16(12): 1-110 Indexing Status Subject indexing assigned by NLM MeSH Adolescent; Adult; Aged; Allergens /drug effects; Anaphylaxis /drug therapy; Antigens, Dermatophagoides /administration & Bee Venoms /adverse effects; Cost-Benefit Analysis; Female; Great Britain; Humans; Male; Middle Aged; Treatment Outcome; Wasp Venoms /adverse effects; Young Adult; dosage /economics /therapeutic use AccessionNumber 22012013067 Date bibliographic record published 18/05/2012 |
|
|
|